FundedIQ
Biotechnology

Retro Biosciences: Funding, Investors & Team (Sep 2026)

Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.

retro.bio LinkedIn San Francisco, United States 11-50 employees
Biopharma Biotechnology Therapeutics
Total raised
$180M
Rounds
2
Latest
Undisclosed round
May 2026

Retro Biosciences has raised $180M across 2 funding rounds on record, the most recent an undisclosed round announced in May 2026.

Retro Biosciences Company Profile and Key Stats

Total funding raised
$180M
across 2 rounds on record
Funding rounds on record
2
1 with no disclosed amount
Latest funding round
Undisclosed round
May 2026
Employees
11-50
reported band
Headquarters
San Francisco, United States

Latest funding round on record: May 2026.

Retro Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
Undisclosed
Undisclosed
$180M

1 of 2 rounds was announced without a disclosed amount and is excluded from the total.

Retro Biosciences raised $180M in an Undisclosed announced in Apr 2022.

4.1 years later, an undisclosed round was announced in May 2026 with no disclosed amount.

Retro Biosciences Founders and Leadership Team

Name
Role
Contact
"joe Betts
Founder
Locked
Joe Betts-Lacroix
CEO
Locked

Contact details for the Retro Biosciences team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Retro Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Funded Startups Like Retro Biosciences in Biotechnology and San Francisco

Companies Similar to Retro Biosciences

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Retro Biosciences Funding FAQs

What does Retro Biosciences do?

Retro Biosciences focus on cellular reprogramming, autophagy and plasma-inspired therapeutics.

How much funding has Retro Biosciences raised?

Retro Biosciences has raised $180M across 2 rounds on record.

When did Retro Biosciences last raise funding?

Retro Biosciences' most recent funding round on record was announced in May 2026. The amount was not disclosed.

Who founded Retro Biosciences?

FundedIQ lists "joe Betts (Founder) at Retro Biosciences.

Who is the CEO of Retro Biosciences?

Joe Betts-Lacroix is listed as CEO at Retro Biosciences.

Where is Retro Biosciences headquartered?

Retro Biosciences is based in San Francisco, California, United States.

How many employees does Retro Biosciences have?

Retro Biosciences is in the 11-50 employee band.

About FundedIQ's Retro Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Retro Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.